Methods Study Design and Setting An observational cohort study was conducted using real-world data from Optums de-identified Clinformatics Data Mart Database (Optum CDM)
The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication
Researchers should always review relevant guidelines and product information before working with any peptide compound
Smart N, et al
Injectable Semaglutide has not been evaluated by the FDA, but side effects are expected to be similar to other Semaglutide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)